GTS Securities’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$364K Sell
5,148
-3,278
-39% -$245K 0.01% 974
2025
Q4
$665K Buy
8,426
+5,875
+230% +$465K 0.02% 629
2025
Q3
$210K Sell
2,551
-331
-11% -$26K 0.01% 1261
2025
Q2
$232K Sell
2,882
-1,049
-27% -$80.9K 0.01% 1045
2025
Q1
$316K Sell
3,931
-1,679
-30% -$140K 0.01% 922
2024
Q4
$459K Sell
5,610
-34,957
-86% -$2.91M 0.02% 651
2024
Q3
$3.35M Buy
40,567
+14,495
+56% +$1.08M 0.01% 1194
2024
Q2
$1.83M Buy
26,072
+12,685
+95% +$906K ﹤0.01% 1570
2024
Q1
$992K Buy
13,387
+828
+7% +$57.7K ﹤0.01% 1982
2023
Q4
$831K Buy
12,559
+8,417
+203% +$527K ﹤0.01% 2329
2023
Q3
$261K Sell
4,142
-31,559
-88% -$1.97M ﹤0.01% 3182
2023
Q2
$2.02M Buy
+35,701
New +$1.98M 0.06% 265

Other funds holding MET

GTS Securities's MET Position: Q1 2026 in Review

GTS Securities reduced its MetLife (MET) stake by 39% in Q1 2026, selling an estimated $245K and leaving 5,148 shares worth $364K. The position accounts for 0.01% of the portfolio, ranked #974.

GTS Securities first reported a position in MET in Q2 2023 and has held it in 12 quarters since. The position peaked at $3.35M in Q3 2024. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • GTS Securities held 5,148 shares of MetLife worth $364K as of Q1 2026.
  • GTS Securities sold 3,278 MetLife shares in Q1 2026, an estimated $245K.
  • MetLife made up 0.01% of GTS Securities's portfolio in Q1 2026, its #974 holding.
  • GTS Securities first reported a position in MetLife in Q2 2023 and has held it in 12 quarters since.
  • GTS Securities's MetLife position peaked at $3.35M in Q3 2024.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.